Skip to main content
OpenTrials
Completed

NCT Number: NCT02140086

Buteyko Based Remedial Breathing Therapy With Children With Asthma

A randomized, controlled trial to investigate the effects of a buteyko based remedial breathing therapy on children with asthma regarding to their symptoms, use of medication and lung function tests.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

6 year–15 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Filderklinik

Filderstadt, Baden-Wurttemberg, 70794, Germany

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • signed informed consent of the parents
  • age 6- 15 years
  • information and consent of the consulting doctor
  • levels of asthma therapy 1-3

Exclusion criteria

  • participation in another study

Treatment and study plan

Buteyko based Remedial Breathing Therapy

Behavioral

Buteyko based remedial Breathing Therapy after Dr. Buteyko

Primary outcomes

  1. Reduction of Betamimetics (-30%) at 3- and/or 6-month follow up

    Time frame: asthmaspezific parameters are measured before and after intervention as well as 3- and 6- month follow up

Secondary outcomes

  1. Asthma Control Questionnaire (ACQ)

    Time frame: parameters are measured before and after intervention as well as 3- and 6- month follow up

    Scores of the ACQ (Asthma Control Questionnaire)

  2. Paediatric Asthma Quality of Life Questionnaire (PAQLQ)

    Time frame: parameters are measured before and after intervention as well as 3- and 6- month follow up

    Scores of PAQLQ (Paediatric Asthma Quality of Life Questionnaire)

  3. ARCIM Questionnaire (AFB)

    Time frame: parameters are measured before and after intervention as well as 3- and 6- month follow up

    Scores of the AFB (ARCIM Questionnaire) regarding to asthma symptoms of the last 3 month (AFB is not validated)

  4. Peak Flow

    Time frame: parameters are measured before and after intervention as well as 3- and 6- month follow up

  5. NO-measurement nasal and oral

    Time frame: parameters are measured before and after intervention as well as 3- and 6- month follow up

  6. Buteyko-Questionnaire

    Time frame: parameters are measured before and after intervention as well as 3- and 6- month follow up

  7. parameters of spirometry

    Time frame: parameters are measured before and after intervention as well as 3- and 6- month follow up

  8. Paediatric asthma caregiver´s quality of life questionnaire (PACQLQ)

    Time frame: parameters are measured before and after intervention as well as 3- and 6- month follow up

Sponsors and collaborators

Lead sponsor

ARCIM Institute Academic Research in Complementary and Integrative Medicine

Other

Registry information

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
May 16, 2014
Registry last updated
Mar 2, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.